Evogene Ltd.

NASDAQ: EVGN · Real-Time Price · USD
1.34
-0.02 (-1.47%)
At close: Aug 15, 2025, 3:49 PM
1.35
0.37%
After-hours: Aug 15, 2025, 04:00 PM EDT

Evogene Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.2M -18.05M -24.65M -20.29M -22.08M -25.22M -22.44M -25.74M -27.72M -29.84M -34.11M -35.29M -32.43M -30.45M -31.12M -28.19M -26.11M
Depreciation & Amortization
2.41M 2.5M 2.57M 2.61M 2.64M 2.61M 2.59M 2.57M 2.54M 2.58M 2.49M 2.39M 2.35M 2.23M 2.31M 2.48M 2.63M
Stock-Based Compensation
1.57M 1.79M 1.59M 1.66M 2M 1.88M 2.06M 1.57M 1.19M 1.19M 1.63M 2.35M 2.49M 2.61M 2.49M 2.4M 2.7M
Other Working Capital
-1.82M -1.03M -30.45K -973.45K 17.78K -598.22K -90K 827K 152K 239K -345K -642K -589K -10K -46K -446K -319K
Other Non-Cash Items
-4.37M -3.3M 1.84M -501.14K -569.14K -134.14K 489K 518K 2.26M 3.08M 2.09M 1.86M -772K -906K 1.27M 1.45M 1.67M
Deferred Income Tax
9K 9K -2K -8K 12K -33K 16K 26K 43K 90K 39K 42K 7K 13K 25K 78K 76K
Change in Working Capital
-3.2M -3.32M -2.18M -3.68M -1.85M -417.18K -621K 402K -533K -771K -1.77M 258K 495K 1.66M 1.53M -300K 312K
Operating Cash Flow
-20.77M -19.7M -20.15M -19.54M -19.18M -21.31M -17.91M -20.65M -22.21M -23.68M -29.63M -28.38M -27.86M -24.84M -23.5M -22.09M -18.73M
Capital Expenditures
-607K -626K -384.49K -468.49K -561.49K -779.49K -898K -907K -1.09M -1.17M -1.11M -1.06M -983K -724K -690K -674K -574K
Cash Acquisitions
-81.95 9.92K 9.83K 9.42K 9.09K 25.09K 25.18K 25.58K 26K n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-16.23M -18.14M -1.44M 2.52M -14.78M -10.58M -10.39M -14.34M -931.84K -905.85K -2.36M -4.38M -4.43M -34.21M -32.5M -30.49M -29.78M
Sales Maturities Of Investments
28.33M 28.33M 2.08M 3.84M 10.12M 10.76M 10.79M 7.13M 3.57M 15.36M 19.33M 19.74M 26.72M 14.49M 420K 4.81M -3.34M
Other Investing Acitivies
50.08K 48.08K 48.08K -3.96M -3.95M -3.93M -3.93M 21.26K 20.85K -5.15K -5.15K n/a n/a n/a 10.1M 10.1M 10.1M
Investing Cash Flow
11.54M 9.62M 312.65K 1.94M -9.17M -4.5M -4.4M -8.06M 1.6M 13.27M 15.85M 14.29M 21.3M -20.44M -22.68M -16.26M -23.6M
Debt Repayment
-813K -901K -907K -885K -861K -836K -1.06M 9.28M 9.11M 9.2M 9.49M -756K -536K -580K -592K -626K -629K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.89M 4.77M 4.75M 166.68K 10.59M 10.72M 10.76M 10.46M 50.87K 82.87K 645.74K 1.02M 1.28M 1.8M 3.28M 3.01M 2.73M
Financial Cash Flow
4.86M 4.66M 4.07M 7.13M 17.73M 18.15M 17.94M 20.31M 9.5M 9.34M 9.6M 1.38M 2.69M 30.28M 41.13M 48.97M 47.87M
Net Cash Flow
-4.42M -5.47M -16.01M -10.75M -11.09M -8.21M -4.53M -8.63M -13.01M -3.35M -5.77M -13.89M -2.63M -13.9M -3.86M 11.68M 6.63M
Free Cash Flow
-21.38M -20.33M -20.54M -20.01M -19.74M -22.09M -18.81M -21.55M -23.3M -24.85M -30.73M -29.44M -28.84M -25.56M -24.2M -22.76M -19.3M